Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study.
By W. Brugge, K. Lewandrowski, E. Lee-lewandrowski, B. Centeno, Tara E. Szydlo, S. Regan, C. F. del Castillo, A. Warshaw. Gastroenterology, 2004
1,386 citations recorded by the source corpus.
Subfields: Oncology, Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/7c8ea22ffb37fd860a51252a17f1b5e0dee14136
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Masao Tanaka
- T. Kamisawa
- C. F. Fernandez-Del Castillo
- M. Canto
- J. Jang
- Philippe Lévy
- R. Hruban
- Takao Ohtsuka
Citations in the corpus
- Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. (2017, methodology): “Chemical analyses of the fl uid CEA and amylase levels as well as cytology of the cyst content obtained by EUS-guided fi ne needle aspiration (EUS-FNA) can be useful, but will not distinguish MCN and IPMN [44,49 e 51,56].”
- ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts (2018, neutral): “Th e most commonly used cutoff level is 192 ng/ml ( 33 ).”
- International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer (2012, background): “The role of EUS-FNA in the clinical management of most pancreatic cysts is limited, given the low accuracy of cytology in cystic lesions, 49 50 and the low volume of cyst fl uid aspirated from small cysts.”